The Food and Drug Administration (FDA) on Tuesday approved freeze-dried blood plasma for use to treat combat injuries from U.S. troops, after a dispute over whether access would be allowed.
House Armed Services Committee Chairman Mac ThornberryWilliam (Mac) McClellan ThornberryOvernight Defense & National Security — Presented by Boeing — Major Russia weapons test stokes tensions Unnamed law enforcement banned under the new NDAA Lobbying world MORE (R-Texas) last year tried to go around the FDA by granting the Department of Defense the ability to allow the freeze-dried plasma use.
“Through our collaborative program with the [Department of Defense], they’ve made clear the importance of access to freeze-dried plasma in initial efforts to control hemorrhage from battlefield trauma,” FDA Commissioner Scott Gottlieb said in a statement. “Granting this authorization will support access to this important product in the event it’s needed. The FDA remains deeply committed to implementing an enduring pathway to ensure that these potentially life-saving medical products are made available in the most expeditious, safe and effective manner possible.”
Plasma is used to help clot blood and stop bleeding, but it generally needs to be refrigerated. The freeze-dried plasma does not need to be refrigerated or go through a long thawing process the way normal frozen plasma, the FDA said, “thus enabling the rapid availability of plasma for use at the point of injury.”